Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of AK102 in Patients With Heterozygous Familial Hypercholesterolemia

NCT04173793 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT04173793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of AK102 in Patients With Heterozygous Familial Hypercholesterolemia
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2019
Completion date
September 26, 2022
Enrollment
109 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heterozygous familial hypercholesterolemia